EP1725233
Lyfjasamsetning sem inniheldur SNS-595 og notkun hennar.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
14.3.2005EP published:
5.1.2011EP application number:
05731600.2
EP translation filed:
5.5.2011Grant published:
15.5.2011EPO information:
European Patent Register
Max expiry date:
13.3.2025Expiry date:
13.3.2019
Title:
PHARMACEUTICAL COMPOSITION COMPRISING SNS-595 AND USES THEREOF
Timeline
Today
14.3.2005EP application
5.1.2011EP Publication
5.5.2011Translation submitted
15.5.2011Registration published
13.3.2019Expires
Owner
Name:
Sunesis Pharmaceuticals, Inc.Address:
395 Oyster Point Blvd., Suite 400, 94080, South San Francisco, CA, US
Name:
SUMITOMO DAINIPPON PHARMA CO., LTD.Address:
6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi, 541-8524, Osaka, JP
Inventor
Name:
HIGAKI, MasaruAddress:
Osaka-shi, Osaka, JP
Name:
NAKAO SatoshiAddress:
Osaka-shi, Osaka,, JP
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
553578 PDate:
15.3.2004Country:
US
Classification
Categories:
A61K 31/44, A61P 35/00, A61P 35/02, A61K 38/18, A61K 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 9.3.2011
Expires: 14.3.2012
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 6.3.2012
Expires: 14.3.2013
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 26.3.2013
Expires: 14.3.2014
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 7.2.2014
Expires: 14.3.2015
Payer: Árnason Faktor
Number: 11
Paid: 10.2.2015
Expires: 14.3.2016
Payer: Árnason Faktor
Number: 12
Paid: 10.2.2016
Expires: 13.3.2017
Payer: Árnason Faktor
Number: 13
Paid: 10.2.2017
Expires: 13.3.2018
Payer: Árnason Faktor
Number: 14
Paid: 8.2.2018
Expires: 13.3.2019
Payer: Árnason Faktor